Which non-stimulant ADHD medications can affect weight?

Canada uses two main non-stimulant classes for ADHD, and each affects weight differently

Non-stimulant ADHD medications are a recognized treatment path in the Canadian ADHD Resource Alliance (CADDRA) guidelines, usually considered when stimulants are not tolerated, not appropriate for medical reasons, or not preferred. In Canada the options approved for ADHD fall into two classes. The first is a selective norepinephrine reuptake inhibitor, which increases the availability of norepinephrine in the brain. The second is the extended-release alpha-2 adrenergic agonist class, medications originally developed to lower blood pressure that also act on attention and impulse-control circuits in the prefrontal cortex. Some prescribers also use certain antidepressants off-label for ADHD, which have their own weight profiles.

Because these classes work through different mechanisms, their effects on appetite and weight are not the same. The table below summarizes what Health Canada product monographs and CADDRA guidance describe as the typical pattern. It is a guide to what to watch for, not a prediction of what will happen to you.

Appetite changes come from how each class acts on the nervous system

The norepinephrine reuptake inhibitor class shares some of the appetite-suppressing effect seen with stimulants, though generally to a lesser degree, because norepinephrine signalling influences hunger and satiety as well as attention. Nausea in the first days of treatment is common and tends to be worse on an empty stomach, which is one reason prescribers often suggest taking it with food. For most people appetite recovers partly or fully as the body adjusts, but a minority continue to eat less and gradually lose weight.

The alpha-2 agonist class works differently. It calms sympathetic nervous system activity, which is why its most common effects are sleepiness, low energy and a slightly lower heart rate and blood pressure. Lower activity levels and sedation can translate into eating more or moving less, and some product monographs list increased appetite or weight gain. Not everyone experiences this, and it is usually less dramatic than the appetite suppression seen with stimulants, but it is a real pattern worth tracking. For a broader comparison of the classes, see how stimulant and non-stimulant ADHD medications compare.

Weight effects matter more for some people than others

A small change in appetite is a minor issue for many adults and a significant one for others. Tell your prescriber before starting if any of the following apply, because it may shape which non-stimulant is chosen and how closely you are monitored:

• Teenagers who are still growing. Height and weight are tracked on growth charts, and persistent appetite loss is taken seriously in youth.
• A history of an eating disorder. Any medication that suppresses appetite needs careful discussion, and some prescribers will steer away from it.
• Already underweight or struggling to maintain weight. Even modest appetite loss can be unwelcome.
• Living with diabetes, heart disease or obesity-related conditions. Weight gain from the alpha-2 class may interact with other health goals.
• Taking other medications that affect weight. Some antidepressants, antipsychotics and mood stabilizers already shift appetite, and effects can stack.
• Irregular eating patterns linked to ADHD itself. Forgetting meals is common with ADHD, and a medication that further dulls hunger can compound it.

Weight is a standard part of medication monitoring, alongside heart rate and blood pressure

CADDRA guidance recommends that prescribers record weight at baseline and at follow-up visits for anyone taking ADHD medication, together with blood pressure and heart rate. For children and teens, height is added so growth can be plotted over time. For the alpha-2 class, blood pressure and pulse get particular attention because the medication lowers both. For the norepinephrine reuptake inhibitor, prescribers also ask about nausea, sleep, mood and, in the early weeks, any unusual changes in thinking or behaviour.

Monitoring is practical rather than formal. A home scale, a note of how often you are skipping meals and a sense of your energy levels are enough for most follow-up conversations. Finding Focus follow-up appointments ask about these points directly, and the page on what to track when starting ADHD medication gives a simple structure. Virtual care works well for this kind of monitoring because the information comes from you between visits rather than from a single reading in a clinic.

If your weight changes, adjust with your prescriber rather than stopping on your own

A few kilograms either way in the first months is common and not usually a reason to change treatment on its own. What matters is the trend, how you feel, and whether the change is affecting your health or your willingness to continue. Options your prescriber may discuss include:

• Timing and food. Taking the norepinephrine reuptake inhibitor with a meal reduces nausea, and scheduling a substantial breakfast before appetite dips helps.
• Dose adjustments. Non-stimulants are started low and increased gradually, and a slower titration sometimes reduces appetite and sedation effects.
• Structured eating. Alarms for meals, prepared snacks and liquid calories are practical workarounds for muted hunger.
• Activity and sleep review. With the alpha-2 class, daytime drowsiness is often the real driver of weight gain, and evening dosing or a dose change may help.
• Switching class. If one class causes a persistent problem, the other, or a stimulant, may suit you better.
• Checking for other causes. Thyroid changes, mood changes and other medications can produce weight shifts that are wrongly blamed on ADHD treatment.

Non-stimulants should not be stopped abruptly without advice, particularly the alpha-2 class, where sudden discontinuation can cause a rebound rise in blood pressure. If you are being treated at Finding Focus, raise weight concerns at any follow-up or message the clinic between appointments. If you are considering a non-stimulant for the first time, the blog post on when non-stimulant medications are prescribed explains how the choice is made.